Literature DB >> 33163898

Alignment of Alzheimer's Disease Amyloid-β Peptide and Herpes Simplex Virus-1 pUL15 C-Terminal Nuclease Domain.

Steven Lehrer1, Peter H Rheinstein2.   

Abstract

BACKGROUND: The cause of Alzheimer's disease (AD) is poorly understood. Neurotropic microbes, particularly herpesviruses, might set off chronic neuroinflammation. Amyloid-β (Aβ) has antimicrobial properties and could represent a brain defense against infection.
OBJECTIVE: We searched for protein sequence alignment between herpes simplex virus type I (HSV-1) HSV-2, and Aβ.
METHODS: Protein data bank (pdb) structures for Aβ, HSV-1, and HSV-2 were searched on the RCSB Protein Data Bank. The protein structures were superimposed and aligned on PYMOL v 2.3.4.
RESULTS: For HSV-1 and Aβ, amino acid residues ser549 - his569 of HSV-1 aligned closely with residues asp7 - asn27 of Aβ. For HSV-2 and Aβ, amino acid residues of HSV-2 aligned less closely than those of HSV-1 with residues of Aβ.
CONCLUSION: Conjugating and binding to the same alpha helix in the HSV-1 protease, Aβ could be marking HSV-1 for attack by the immune system, providing a rapid inherited immune response to a destructive neurotropic virus that would otherwise require the more time-consuming involvement of T-cells, B-cells, and the adaptive immune system. But older people do not respond to viral infections as well as younger individuals. When HSV-1 infection advances in an old person, more and more amyloid is produced, forming an adhesive web. As the brain tries to hold the pathologic process in check, neuroinflammation increases and spreads. Progressive neurodegeneration and cognitive decline are the outcome.
© 2020 – IOS Press and the authors. All rights reserved.

Entities:  

Keywords:  Alignment; Alzheimer’s disease; amyloid-β; protein; virus

Year:  2020        PMID: 33163898      PMCID: PMC7592838          DOI: 10.3233/ADR-200231

Source DB:  PubMed          Journal:  J Alzheimers Dis Rep        ISSN: 2542-4823


INTRODUCTION

The cause of Alzheimer’s disease (AD) is poorly understood. The disease process is associated with amyloid-β (Aβ) plaques, tau neurofibrillary tangles, and neuroinflammation. In 1991, the amyloid hypothesis postulated that Aβ accumulation is a key element [1]. Aβ was supposed to stimulate both the development of tau neurofibrillary tangles and neuroinflammation. Aβ, tau, and inflammation each led to the malfunction and destruction of neurons and synapses. It follows that clearing the brain of Aβ would be beneficial, which has not been the case. Therefore, Aβ is likely a result, not a cause, of AD [2, 3]. A newer disease model suggests that infection stimulates neuroinflammation, resulting in AD. Neurotropic microbes, particularly herpesviruses, might set off chronic neuroinflammation. Multiple reports link herpes simplex virus type 1 (HSV-1) to AD [4, 5]. DNA of HSV-1 is identified more often in the brains of individuals with AD than in healthy controls; and the viral DNA is especially prominent within Aβ plaques [6]. In addition, a herpes simplex virus glycoprotein B fragment with homology to Aβ induces fibril formation and is neurotoxic, suggesting a possible role for this infectious agent in the pathophysiology of sporadic cases of AD [7]. Aβ has antimicrobial properties [8] and could represent a brain defense against infection [9]. To evaluate this possibility, we searched for protein sequence alignment between HSV-1 and Aβ.

METHODS

Protein data bank (pdb) entries were searched on the RCSB Protein Data Bank. We identified three that allowed us to examine the relationship of Aβ to HSV-1, and HSV-2. 1IYT (Fig. 1A). Solution structure of the AD Aβ peptide, Method: solution NMR, Deposited: 2002-09-06 Released: 2003-02-11 [10].
Fig.1

A) Structure of the herpes simplex virus (HSV-1) DNA-packaging motor pUL15 C-terminal nuclease domain. Arrow points to alpha helix that aligns with Aβ-peptide. B) Solution structure of the Alzheimer’s disease Aβ-peptide. Arrow points to alpha helix that aligns with HSV-1.

4IOX (Fig. 1B). The structure of the herpes simplex virus (HSV-1) DNA-packaging motor pUL15 C-terminal nuclease domain, Method: X-Ray diffraction, Resolution: 2.46 Å, deposited: 2013-01-08 released: 2013-05-01 [11]. pUL15C, the C-terminal nuclease domain, is required for herpesvirus genome processing and packaging. pUL15 and its homologues are highly conserved and have attracted considerable interest as drug targets [12]. 1AT3 (Fig. 3A, B). Herpes simplex virus (HSV-2) protease. Method: X-Ray diffraction, Resolution: 2.50 Å, deposited: 1997-08-16, released: 1998-10-14 [13].
Fig.3

A) HSV-2 aligned with Aβ. Amino acid residues of HSV-2 aligned less closely (RMSD = 2.67Å) than those of HSV-1 with residues of Aβ. B) Closeup of aligned alpha helices of HSV-2 and Aβ.

A) Structure of the herpes simplex virus (HSV-1) DNA-packaging motor pUL15 C-terminal nuclease domain. Arrow points to alpha helix that aligns with Aβ-peptide. B) Solution structure of the Alzheimer’s disease Aβ-peptide. Arrow points to alpha helix that aligns with HSV-1. The protein structures were superimposed and aligned on Pymol v 2.3.4. Pymol is an open source molecular visualization system. Pymol can produce high-quality 3D images of small molecules and biological macromolecules, such as proteins. We utilized the Pymol super command, which super aligns two protein selections. Super does a sequence-independent structure-based dynamic programming alignment (unlike the align command) followed by a series of refinement cycles intended to improve the fit by eliminating pairing with high relative variability. The super command is more reliable than the align command for proteins with low sequence similarity. To evaluate conservation and alignment of the Aβ genome across species, we used BLAT, the Blast-Like Alignment Tool of the UCSC Genome Browser [14]. BLAT can align a user sequence of 25 bases or more to the genome. Because some level of mismatch is tolerated, cross-species alignments may be performed provided the species have not diverged too far from each other; this capability allowed comparison of the Mouse Mammary Tumor Virus genome to the human genome [15]. BLAT calculates a percent identity score to indicate differences between sequences without a perfect match (i.e., without 100% identity). The differences include mismatches and gaps [16].

RESULTS

For HSV-1 and Aβ, Pymol performed 6 cycles of calculations on 124 aligned atoms, final root mean square deviation of atomic positions (RMSD) = 0.937Å for 94 atoms (Table 1). Amino acid residues ser549 – his569 of the HSV-1 protease aligned closely with residues asp7 - asn27 of Aβ (Fig. 2A, B).
Table 1

Pymol alignment cycles and RMSD (root mean square deviation of atomic positions) score for HSV-1 and Aβ. The root-mean-square deviation of atomic positions is the measure of the average distance (Å) between the atoms of superimposed proteins. The RMSD (0.937Å) indicates good alignment of the Aβ and HSV-1 residues

MatchAlign: aligning residues (864 versus 42)
MatchAlign: score 77.391
ExecutiveAlign: 124 atoms aligned.
ExecutiveRMS: 9 atoms rejected during cycle 1 (RMSD = 2.08).
ExecutiveRMS: 8 atoms rejected during cycle 2 (RMSD = 1.63).
ExecutiveRMS: 6 atoms rejected during cycle 3 (RMSD = 1.32).
ExecutiveRMS: 5 atoms rejected during cycle 4 (RMSD = 1.12).
ExecutiveRMS: 2 atoms rejected during cycle 5 (RMSD = 0.97).
Executive: RMSD = 0.937Å (94 to 94 atoms)
Fig.2

HSV-1 aligned with Aβ. A) Arrow points to closely aligned (RMSD = 0.937Å) alpha helices of HSV-1 (green) and Aβ (blue). B) Closeup of aligned alpha helices of HSV-1 and Aβ.

Pymol alignment cycles and RMSD (root mean square deviation of atomic positions) score for HSV-1 and Aβ. The root-mean-square deviation of atomic positions is the measure of the average distance (Å) between the atoms of superimposed proteins. The RMSD (0.937Å) indicates good alignment of the Aβ and HSV-1 residues HSV-1 aligned with Aβ. A) Arrow points to closely aligned (RMSD = 0.937Å) alpha helices of HSV-1 (green) and Aβ (blue). B) Closeup of aligned alpha helices of HSV-1 and Aβ. For HSV-2 and Aβ, Pymol performed 6 cycles of calculations on 124 aligned atoms, final RMSD = 2.67Å for 94 atoms. Amino acid residues of HSV-2 aligned less closely than those of HSV-1 with residues of Aβ (Fig. 3A, B). A) HSV-2 aligned with Aβ. Amino acid residues of HSV-2 aligned less closely (RMSD = 2.67Å) than those of HSV-1 with residues of Aβ. B) Closeup of aligned alpha helices of HSV-2 and Aβ. Results of the cross-species comparison of Aβ are shown in Fig. 4. There is a high degree of alignment and conservation of human Aβ (chr 21q21.3) in Aβ of the rhesus monkey and 27 other primates, but much less alignment and conservation in the mouse, dog, and elephant, even less in the chicken, western clawed frog (Xenopus tropicalis), zebrafish, and lamprey. The rhesus macaque diverged from ancestors of Homo sapiens about 25 million years ago [17].
Fig.4

Alignment of 42 amino acid residue human Aβ across species in the UCSC genome browser. There is a high degree of alignment and conservation of human Aβ (chr 21q21.3) in Aβ of the rhesus monkey (solid black horizontal line) and 27 other primates, but much less alignment and conservation in the mouse, dog, and elephant, even less in the chicken, western clawed frog (Xenopus tropicalis), zebrafish, and lamprey. The high degree of conservation of Aβ in primates suggests that Aβ is important for survival.

Alignment of 42 amino acid residue human Aβ across species in the UCSC genome browser. There is a high degree of alignment and conservation of human Aβ (chr 21q21.3) in Aβ of the rhesus monkey (solid black horizontal line) and 27 other primates, but much less alignment and conservation in the mouse, dog, and elephant, even less in the chicken, western clawed frog (Xenopus tropicalis), zebrafish, and lamprey. The high degree of conservation of Aβ in primates suggests that Aβ is important for survival.

DISCUSSION

Aβ is an ancient neuropeptide expressed in vertebrates. Many vertebrate species share the human Aβ sequence (Fig. 4), which has been highly conserved over millions of years and therefore must be important for survival [18]. The antimicrobial properties of Aβ could be one of the reasons for Aβ conservation. In vivo, Aβ may behave like ubiquitin, and some studies have suggested that a relationship between Aβ and ubiquitin that may be involved in AD [19]. Ubiquitin is a small (8.6 kDa) regulatory protein present in most tissues of eukaryotic organisms, that is, it occurs ubiquitously [20]. The conjugation and binding of ubiquitin to a substrate protein is called ubiquitination. Ubiquitination affects proteins in many ways; one is especially important: Ubiquitin can mark a protein for degradation by the proteasome, a protein complex which destroys unneeded or damaged proteins by proteolysis, breaking peptide bonds [21]. Similarly, conjugating and binding to an alpha helix in the HSV-1 protease, Aβ could be marking HSV-1 for attack by the immune system. Aβ could evoke a rapid immune response to a destructive neurotropic virus that would otherwise require the more time-consuming involvement of T-cells, B-cells, and the adaptive immune system. A weakness in our hypothesis is that HSV-1 is an enveloped virus. If Aβ behaves as an immunoglobulin/opsonin (ubiquitin) for phagocytic cells, the virus envelope should be destroyed first. But Aβ could have a dual action: 1) interacting with the membrane and destroying it, probably by pore formation, as many studies suggest [22-25], and then 2) acting as an immunoglobulin/opsonin (ubiquitin) for phagocytic cells. Aβ did not align as well with HSV-2 as with HSV-1. This finding may be related to other studies indicating a closer HSV-1 than HSV-2 association with AD. Few studies suggest an HSV-2 AD link. Older people do not handle viral infections as well as younger individuals. A common denominator of age-associated frailty is increased baseline inflammation, called inflammaging, that is present in older individuals. Recent studies have shown that the presence of excessive inflammation can inhibit immunity in both animals and humans, increasing the morbidity and mortality of viral infections [26]. As HSV-1 infection advances in an old person, more and more amyloid is produced, forming an adhesive web, as the brain tries to hold the pathologic process in check. Meanwhile, neuroinflammation increases and spreads. Progressive neurodegeneration and cognitive decline are the outcome.

CONFLICT OF INTEREST

The authors have no conflict of interest to report.
  26 in total

1.  Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide.

Authors:  D H Cribbs; B Y Azizeh; C W Cotman; F M LaFerla
Journal:  Biochemistry       Date:  2000-05-23       Impact factor: 3.162

2.  Aging immunity may exacerbate COVID-19.

Authors:  Arne N Akbar; Derek W Gilroy
Journal:  Science       Date:  2020-07-17       Impact factor: 47.728

3.  The antimicrobial protection hypothesis of Alzheimer's disease.

Authors:  Robert D Moir; Richard Lathe; Rudolph E Tanzi
Journal:  Alzheimers Dement       Date:  2018-10-09       Impact factor: 21.566

4.  Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.

Authors:  Orlando Crescenzi; Simona Tomaselli; Remo Guerrini; Severo Salvadori; Anna M D'Ursi; Piero Andrea Temussi; Delia Picone
Journal:  Eur J Biochem       Date:  2002-11

5.  Evolutionary and biomedical insights from the rhesus macaque genome.

Authors:  Richard A Gibbs; Jeffrey Rogers; Michael G Katze; Roger Bumgarner; George M Weinstock; Elaine R Mardis; Karin A Remington; Robert L Strausberg; J Craig Venter; Richard K Wilson; Mark A Batzer; Carlos D Bustamante; Evan E Eichler; Matthew W Hahn; Ross C Hardison; Kateryna D Makova; Webb Miller; Aleksandar Milosavljevic; Robert E Palermo; Adam Siepel; James M Sikela; Tony Attaway; Stephanie Bell; Kelly E Bernard; Christian J Buhay; Mimi N Chandrabose; Marvin Dao; Clay Davis; Kimberly D Delehaunty; Yan Ding; Huyen H Dinh; Shannon Dugan-Rocha; Lucinda A Fulton; Ramatu Ayiesha Gabisi; Toni T Garner; Jennifer Godfrey; Alicia C Hawes; Judith Hernandez; Sandra Hines; Michael Holder; Jennifer Hume; Shalini N Jhangiani; Vandita Joshi; Ziad Mohid Khan; Ewen F Kirkness; Andrew Cree; R Gerald Fowler; Sandra Lee; Lora R Lewis; Zhangwan Li; Yih-Shin Liu; Stephanie M Moore; Donna Muzny; Lynne V Nazareth; Dinh Ngoc Ngo; Geoffrey O Okwuonu; Grace Pai; David Parker; Heidie A Paul; Cynthia Pfannkoch; Craig S Pohl; Yu-Hui Rogers; San Juana Ruiz; Aniko Sabo; Jireh Santibanez; Brian W Schneider; Scott M Smith; Erica Sodergren; Amanda F Svatek; Teresa R Utterback; Selina Vattathil; Wesley Warren; Courtney Sherell White; Asif T Chinwalla; Yucheng Feng; Aaron L Halpern; Ladeana W Hillier; Xiaoqiu Huang; Pat Minx; Joanne O Nelson; Kymberlie H Pepin; Xiang Qin; Granger G Sutton; Eli Venter; Brian P Walenz; John W Wallis; Kim C Worley; Shiaw-Pyng Yang; Steven M Jones; Marco A Marra; Mariano Rocchi; Jacqueline E Schein; Robert Baertsch; Laura Clarke; Miklós Csürös; Jarret Glasscock; R Alan Harris; Paul Havlak; Andrew R Jackson; Huaiyang Jiang; Yue Liu; David N Messina; Yufeng Shen; Henry Xing-Zhi Song; Todd Wylie; Lan Zhang; Ewan Birney; Kyudong Han; Miriam K Konkel; Jungnam Lee; Arian F A Smit; Brygg Ullmer; Hui Wang; Jinchuan Xing; Richard Burhans; Ze Cheng; John E Karro; Jian Ma; Brian Raney; Xinwei She; Michael J Cox; Jeffery P Demuth; Laura J Dumas; Sang-Gook Han; Janet Hopkins; Anis Karimpour-Fard; Young H Kim; Jonathan R Pollack; Tomas Vinar; Charles Addo-Quaye; Jeremiah Degenhardt; Alexandra Denby; Melissa J Hubisz; Amit Indap; Carolin Kosiol; Bruce T Lahn; Heather A Lawson; Alison Marklein; Rasmus Nielsen; Eric J Vallender; Andrew G Clark; Betsy Ferguson; Ryan D Hernandez; Kashif Hirani; Hildegard Kehrer-Sawatzki; Jessica Kolb; Shobha Patil; Ling-Ling Pu; Yanru Ren; David Glenn Smith; David A Wheeler; Ian Schenck; Edward V Ball; Rui Chen; David N Cooper; Belinda Giardine; Fan Hsu; W James Kent; Arthur Lesk; David L Nelson; William E O'brien; Kay Prüfer; Peter D Stenson; James C Wallace; Hui Ke; Xiao-Ming Liu; Peng Wang; Andy Peng Xiang; Fan Yang; Galt P Barber; David Haussler; Donna Karolchik; Andy D Kern; Robert M Kuhn; Kayla E Smith; Ann S Zwieg
Journal:  Science       Date:  2007-04-13       Impact factor: 47.728

6.  Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex.

Authors:  S S Hoog; W W Smith; X Qiu; C A Janson; B Hellmig; M S McQueney; K O'Donnell; D O'Shannessy; A G DiLella; C Debouck; S S Abdel-Meguid
Journal:  Biochemistry       Date:  1997-11-18       Impact factor: 3.162

Review 7.  Alzheimer disease pathology as a host response.

Authors:  Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

Review 8.  Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.

Authors:  Liang Hong; Han-Chang Huang; Zhao-Feng Jiang
Journal:  Neurol Res       Date:  2014-03       Impact factor: 2.448

Review 9.  Low Evolutionary Selection Pressure in Senescence Does Not Explain the Persistence of Aβ in the Vertebrate Genome.

Authors:  Robert D Moir; Rudolph E Tanzi
Journal:  Front Aging Neurosci       Date:  2019-03-28       Impact factor: 5.750

10.  The UCSC genome browser and associated tools.

Authors:  Robert M Kuhn; David Haussler; W James Kent
Journal:  Brief Bioinform       Date:  2012-08-20       Impact factor: 11.622

View more
  2 in total

1.  Alzheimer's Disease and Parkinson's Disease May Result from Reactivation of Embryologic Pathways Silenced at Birth.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Discov Med       Date:  2021 Mar-Apr       Impact factor: 2.970

2.  Herpes Zoster Vaccination Reduces Risk of Dementia.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.